In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?

Gonorrhea may become untreatable, and new treatment options are essential. We investigated the in vitro activity of the first fluoroketolide, solithromycin. Clinical Neisseria gonorrhoeae isolates and reference strains (n = 246), including the two extensively drug-resistant strains H041 and F89 and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Golparian, Daniel, Fernandes, Prabhavathi, Ohnishi, Makoto, Jensen, Jörgen S., Unemo, Magnus
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2012
Aiheet:
Susceptibility
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346660/
https://ncbi.nlm.nih.gov/pubmed/22354296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00036-12
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia